ALK Abell Financials
| ALK-B Stock | DKK 162.00 3.30 2.08% |
ALK |
Understanding current and past ALK Abell Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ALK Abell's financial statements are interrelated, with each one affecting the others. For example, an increase in ALK Abell's assets may result in an increase in income on the income statement.
Please note, the presentation of ALK Abell's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ALK Abell's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ALK Abell's management manipulating its earnings.
ALK Abell Stock Summary
ALK Abell competes with Ambu AS, GN Store, FLSmidth, NKT AS, and Genmab AS. ALK-Abell AS, a pharmaceutical company, develops and markets products and services for allergy and allergic asthma in Europe, North America, and internationally. ALK-Abell AS was founded in 1923 and is headquartered in Hrsholm, Denmark. ALK Abell operates under Biotechnology classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 2379 people.| Instrument | Denmark Stock View All |
| Exchange | Copenhagen Exchange |
| ISIN | DK0061802139 |
| Business Address | Boge Alle 6-8, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.alk.net |
| Phone | 45 45 74 75 76 |
| Currency | DKK - Danish Krone |
You should never invest in ALK Abell without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of ALK Stock, because this is throwing your money away. Analyzing the key information contained in ALK Abell's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
ALK Abell Key Financial Ratios
ALK Abell's financial ratios allow both analysts and investors to convert raw data from ALK Abell's financial statements into concise, actionable information that can be used to evaluate the performance of ALK Abell over time and compare it to other companies across industries.| Return On Equity | 0.0897 | |||
| Return On Asset | 0.0516 | |||
| Target Price | 153.83 | |||
| Beta | 0.36 | |||
| Z Score | 71.4 |
ALK Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ALK Abell's current stock value. Our valuation model uses many indicators to compare ALK Abell value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ALK Abell competition to find correlations between indicators driving ALK Abell's intrinsic value. More Info.ALK Abell AS is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about 0.58 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ALK Abell AS is roughly 1.74 . Comparative valuation analysis is a catch-all model that can be used if you cannot value ALK Abell by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ALK Abell's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.ALK Abell AS Systematic Risk
ALK Abell's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ALK Abell volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on ALK Abell AS correlated with the market. If Beta is less than 0 ALK Abell generally moves in the opposite direction as compared to the market. If ALK Abell Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ALK Abell AS is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ALK Abell is generally in the same direction as the market. If Beta > 1 ALK Abell moves generally in the same direction as, but more than the movement of the benchmark.
ALK Abell December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of ALK Abell help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ALK Abell AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of ALK Abell AS based on widely used predictive technical indicators. In general, we focus on analyzing ALK Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ALK Abell's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 13.81 | |||
| Value At Risk | (2.90) | |||
| Potential Upside | 2.57 |
Complementary Tools for ALK Stock analysis
When running ALK Abell's price analysis, check to measure ALK Abell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ALK Abell is operating at the current time. Most of ALK Abell's value examination focuses on studying past and present price action to predict the probability of ALK Abell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ALK Abell's price. Additionally, you may evaluate how the addition of ALK Abell to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |